Samiha Akkaya
Research Subjects
Research Interests
Samiha Akkaya has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Esra Ensaroglu
Department of Infectious Diseases and Clinical Microbiology, Bakırköy Dr. Sadi Konuk Training Research Hospital, İstanbul, Türkiye
2 shared publications - Kadriye Kart Yaşar
Clinic of Infectious Diseases and Clinical Microbiology, University of Health Sciences, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Istanbul, Türkiye
2 shared publications - Yusuf Emre Ozdemir
Department of Infectious Diseases and Clinical Microbiology, Bakirkoy Dr Sadi Konuk Training and Research Hospital, Istanbul, Turkey
2 shared publications - Abdullah Uçar
SAKARYA UNIVERSITY, SCHOOL OF MEDICINE, DEPARTMENT OF INTERNAL MEDICINE, DEPARTMENT OF PUBLIC HEALTH
1 shared publication - Adem Karbuz
Council of Forensic Medicine, Ministry of Justice, Republic of Turkiye, Istanbul, Turkiye
1 shared publication Aysegul Inci Sezen
1 shared publication
Latest Publications
- Open Access
- 1 January 2026
- Published by Wiley in Health & Social Care in the Community
- Vol. 2026 (1)
Health Literacy Levels and Associated Factors Among People Living With HIV: A Cross‐Sectional Study in a Research Hospital in Türkiye
Background: Health literacy (HL) is the ability to access, understand and utilize information and health services. People living with HIV (PLWH) with high HL have higher adherence to antiretroviral therapy (ART) and better long‐term health outcomes. Since HL has a crucial impact on health outcomes, we conducted the first study in Türkiye to identify factors associated with HL in PLWH. Methods: A questionnaire containing demographic data and the HÜ‐SOY scale to measure HL levels was completed by 244 PLWH who agreed to participate in our study. The achieved sample size was sufficient to detect small‐to‐moderate effect sizes, as supported by power and sensitivity analyses. Regarding adherence to ART, the individuals were asked whether they had not taken ART for two consecutive days or for a total of 30 days in the last year. Results: HL levels were lower in patients with low ART adherence ( p = 0.007). A higher level of HL was observed in individuals whose income levels exceeded their expenses and in those with higher education levels ( p < 0.001). Those who did not want to specify their sexual orientation had lower levels of HL ( p = 0.001). The HL level was higher in the group with higher CD4 count but not statistically significant. In multivariable linear regression analysis, higher educational level and sexual orientation remained independently associated with HL levels. Conclusions: HL levels should be assessed before starting ART, and PLWH with low HL should be considered at high risk for treatment nonadherence. On the other hand, for individuals who do not want to disclose their sexual orientation, interventions that increase their HL levels may be beneficial for them to express themselves freely.
- 1 January 2026
- Published by Wiley in Health & Social Care in the Community
- Vol. 2026 (1)
Open AccessHealth Literacy Levels and Associated Factors Among People Living With HIV: A Cross‐Sectional Study in a Research Hospital in Türkiye
Background: Health literacy (HL) is the ability to access, understand and utilize information and health services. People living with HIV (PLWH) with high HL have higher adherence to antiretroviral therapy (ART) and better long‐term health outcomes. Since HL has a crucial impact on health outcomes, we conducted the first study in Türkiye to identify factors associated with HL in PLWH. Methods: A questionnaire containing demographic data and the HÜ‐SOY scale to measure HL levels was completed by 244 PLWH who agreed to participate in our study. The achieved sample size was sufficient to detect small‐to‐moderate effect sizes, as supported by power and sensitivity analyses. Regarding adherence to ART, the individuals were asked whether they had not taken ART for two consecutive days or for a total of 30 days in the last year. Results: HL levels were lower in patients with low ART adherence ( p = 0.007). A higher level of HL was observed in individuals whose income levels exceeded their expenses and in those with higher education levels ( p < 0.001). Those who did not want to specify their sexual orientation had lower levels of HL ( p = 0.001). The HL level was higher in the group with higher CD4 count but not statistically significant. In multivariable linear regression analysis, higher educational level and sexual orientation remained independently associated with HL levels. Conclusions: HL levels should be assessed before starting ART, and PLWH with low HL should be considered at high risk for treatment nonadherence. On the other hand, for individuals who do not want to disclose their sexual orientation, interventions that increase their HL levels may be beneficial for them to express themselves freely.
- Open Access
- 27 March 2025
- Published by Doc Design and Informatics Co. Ltd. in Infectious Diseases and Clinical Microbiology
- Vol. 7 (1) , 88-96
Clinical Outcomes and Microbiological Profiles of Patients with Culture-Confirmed Peritonitis
Peritonitis presents an inflammation of the peritoneal cavity that can develop because of infectious (bacteria, viruses, parasites, etc.) and non-infectious (chemical agents, foreign substances, etc.) causes. Infectious peritonitis is divided into three classes based on
- 27 March 2025
- Published by Doc Design and Informatics Co. Ltd. in Infectious Diseases and Clinical Microbiology
- Vol. 7 (1) , 88-96
Open AccessClinical Outcomes and Microbiological Profiles of Patients with Culture-Confirmed Peritonitis
Peritonitis presents an inflammation of the peritoneal cavity that can develop because of infectious (bacteria, viruses, parasites, etc.) and non-infectious (chemical agents, foreign substances, etc.) causes. Infectious peritonitis is divided into three classes based on
- 1 March 2024
- Published by Bentham Science Publishers Ltd. in Current HIV Research
- Vol. 22 (2) , 120-127
Assessment of Knowledge and Concern of People Living with HIV Regarding Human Mpox and Vaccination
Introduction: Mpox virus is an orthopoxvirus that causes the zoonotic infectious disease known as mpox. The disease can also spread from humans to humans. It can be transmitted through contact with bodily fluids, lesions on the skin, or internal mucosal surfaces. Method: The number of mpox cases increased during the COVID-19 pandemic. Early diagnosis and prompt management of mpox are critical in people living with HIV (PLHIV). In this study, a cross-sectional survey was conducted among PLHIV followed at the outpatient clinic between 20 April–20 August 2023. A questionnaire was used to assess the knowledge and anxiety levels of patients as well as their opinions about vaccination against mpox. The severity of symptoms in the past two weeks was assessed using the Generalised Anxiety Disorder 7-item scale. A total of 203 PLHIV were interviewed for this survey study. Result: The mean age was 39.37±11.93. The majority of them were male (86.7%), and 41.4% were men who have sex with men (MSM). Only 21 of the surveyed participants (10.4%) had a “good knowledge” score about mpox. The mean knowledge score on human Mpox was 2.05 (min:0-max:8), and 107 (52.7%) had a score of 0. Conclusion: The future study should focus on continuous education, promoting awareness through programs and establishing measures to successfully overcome identified variables that contribute to mpox pandemic understanding and attitudes. Applying the lessons learned from the COVID-19 pandemic will help the management of mpox virus.
- 1 March 2024
- Published by Bentham Science Publishers Ltd. in Current HIV Research
- Vol. 22 (2) , 120-127
Assessment of Knowledge and Concern of People Living with HIV Regarding Human Mpox and Vaccination
Introduction: Mpox virus is an orthopoxvirus that causes the zoonotic infectious disease known as mpox. The disease can also spread from humans to humans. It can be transmitted through contact with bodily fluids, lesions on the skin, or internal mucosal surfaces. Method: The number of mpox cases increased during the COVID-19 pandemic. Early diagnosis and prompt management of mpox are critical in people living with HIV (PLHIV). In this study, a cross-sectional survey was conducted among PLHIV followed at the outpatient clinic between 20 April–20 August 2023. A questionnaire was used to assess the knowledge and anxiety levels of patients as well as their opinions about vaccination against mpox. The severity of symptoms in the past two weeks was assessed using the Generalised Anxiety Disorder 7-item scale. A total of 203 PLHIV were interviewed for this survey study. Result: The mean age was 39.37±11.93. The majority of them were male (86.7%), and 41.4% were men who have sex with men (MSM). Only 21 of the surveyed participants (10.4%) had a “good knowledge” score about mpox. The mean knowledge score on human Mpox was 2.05 (min:0-max:8), and 107 (52.7%) had a score of 0. Conclusion: The future study should focus on continuous education, promoting awareness through programs and establishing measures to successfully overcome identified variables that contribute to mpox pandemic understanding and attitudes. Applying the lessons learned from the COVID-19 pandemic will help the management of mpox virus.
- 1 January 1999
- Published by Taylor & Francis in Journal of Dermatological Treatment
- Vol. 10 (3) , 189-193
Comparative study of the efficacy and tolerability of 4 weeks of terbinafine therapy with 8 weeks of griseofulvin therapy in children with tinea capitis
Background: Ringworm of the scalp is a dermatophyte infection prevalent in pre-school and school-aged children. Tinea capitis is one of the few superficial fungal infections that does not adequately respond to topical treatment and requires 6-8 weeks of oral antifungal therapy. The aim of this double-blind study was to compare the efficacy and tolerability of terbinafine therapy with griseofulvin therapy in children with mycologically proven tinea capitis. METHODS: In a randomized, double-blind study, efficacy and tolerability of terbinafine given orally once daily for 4 weeks were compared with those of griseofulvin given orally once daily for 8 weeks. A total of 78 subjects were enrolled (39 in the terbinafine group, and 39 in the griseofulvin group). Among these, 7 subjects in the terbinafine group and 4 subjects in the griseofulvin group dropped out. The study included 67 subjects (32 in the terbinafine group and 35 in the griseofulvin group) and the mean age was 7.0 years (range 2-13 years) in the terbinafine group and 6.6 years (range 2-12 years) in the griseofulvin group. Clinical and mycological examination of hair samples were performed at the initial clinical assessment and after the 2nd, 4th, 6th, 8th and 12th weeks. Biochemical and haematological parameters were measured at the initial clinical assessment and after weeks 4, 8 and 12. RESULTS: At the final follow-up visit (week 12), a mycological cure was recorded in 88.0% of the terbinafine-treated group, compared with 91.0% of the griseofulvin-treated group. Effective treatment (complete disappearance of signs and symptoms and negative mycology, or not more than two signs or symptoms of mild erythema, desquamation or pruritus) was recorded in 78% of subjects in the terbinafine-treated group compared with 74% of subjects in the griseofulvin-treated group. Trichophyton species and Microsporum canis showed similar responsiveness to terbinafine treatment, CONCLUSION: Terbinafine given for 4 weeks was well tolerated and was as effective as griseofulvin used for 8 weeks in the treatment of tinea capitis in children.
- 1 January 1999
- Published by Taylor & Francis in Journal of Dermatological Treatment
- Vol. 10 (3) , 189-193
Comparative study of the efficacy and tolerability of 4 weeks of terbinafine therapy with 8 weeks of griseofulvin therapy in children with tinea capitis
Background: Ringworm of the scalp is a dermatophyte infection prevalent in pre-school and school-aged children. Tinea capitis is one of the few superficial fungal infections that does not adequately respond to topical treatment and requires 6-8 weeks of oral antifungal therapy. The aim of this double-blind study was to compare the efficacy and tolerability of terbinafine therapy with griseofulvin therapy in children with mycologically proven tinea capitis. METHODS: In a randomized, double-blind study, efficacy and tolerability of terbinafine given orally once daily for 4 weeks were compared with those of griseofulvin given orally once daily for 8 weeks. A total of 78 subjects were enrolled (39 in the terbinafine group, and 39 in the griseofulvin group). Among these, 7 subjects in the terbinafine group and 4 subjects in the griseofulvin group dropped out. The study included 67 subjects (32 in the terbinafine group and 35 in the griseofulvin group) and the mean age was 7.0 years (range 2-13 years) in the terbinafine group and 6.6 years (range 2-12 years) in the griseofulvin group. Clinical and mycological examination of hair samples were performed at the initial clinical assessment and after the 2nd, 4th, 6th, 8th and 12th weeks. Biochemical and haematological parameters were measured at the initial clinical assessment and after weeks 4, 8 and 12. RESULTS: At the final follow-up visit (week 12), a mycological cure was recorded in 88.0% of the terbinafine-treated group, compared with 91.0% of the griseofulvin-treated group. Effective treatment (complete disappearance of signs and symptoms and negative mycology, or not more than two signs or symptoms of mild erythema, desquamation or pruritus) was recorded in 78% of subjects in the terbinafine-treated group compared with 74% of subjects in the griseofulvin-treated group. Trichophyton species and Microsporum canis showed similar responsiveness to terbinafine treatment, CONCLUSION: Terbinafine given for 4 weeks was well tolerated and was as effective as griseofulvin used for 8 weeks in the treatment of tinea capitis in children.